Related Experiment Video
Updated: Oct 2, 2025

08:44
Synthesis and Reaction Chemistry of Nanosize Monosodium Titanate
Published on: February 23, 2016
8.8K
Engineered titania nanomaterials in advanced clinical applications
Padmavati Sahare1, Paulina Govea Alvarez1, Juan Manual Sanchez Yanez2
1Centre of Applied Physics and Advanced Technologies (CFATA), National Autonomous University of Mexico, Queretaro, Mexico.
Beilstein Journal of Nanotechnology
|February 28, 2022
Summary
Titanium dioxide (TiO2) nanomaterials show promise for theranostic applications due to their biocompatibility and unique properties. This review explores TiO2-based nanotherapeutics and future challenges in their clinical use.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Nanotechnology enables engineered biocompatible nanomaterials for theranostic use.
- Titanium dioxide (TiO2), a widely studied metal oxide, is gaining attention for clinical applications.
- TiO2's properties like photocatalytic activity, biocompatibility, corrosion resistance, and low toxicity are advantageous.
Purpose of the Study:
- To provide a comprehensive overview of TiO2-based nanotherapeutics.
- To discuss the potential of TiO2 in medical devices and functional moiety integration.
- To highlight future challenges in the field of TiO2 nanotherapeutics.
Main Methods:
- Literature review of recent advancements in TiO2 nanotechnology.
- Analysis of TiO2 properties relevant to biological systems.
- Synthesis of information on theranostic applications and medical device integration.
Main Results:
- TiO2 nanomaterials possess unique properties suitable for theranostic applications.
- TiO2 facilitates the development of innovative medical devices.
- Functional moieties can be integrated with TiO2 to modulate biological responses.
Conclusions:
- TiO2-based nanotherapeutics offer significant potential for revolutionizing therapeutic approaches.
- Further research is needed to address challenges in the clinical application of TiO2 nanotherapeutics.

